DETROIT, Feb. 19, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE), a nanotechnology company focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including consumer products, energy and healthcare, is pleased to announce today that Dr. Patrick Barnabe has joined Nano Labs Strategic Advisory Board. Dr. Barnabe graduated with a Doctor in Medicine degree from the University of Ottawa and obtained his Residency in Family Practice at the University of Montreal. For the past 22 years, Dr. Barnabe has worked as a clinical teacher at the University of Ottawa in the School of Medicine, as well as a family doctor at an independent clinical practice in downtown Ottawa. Currently, he is a designated medical consultant to more than thirty embassies in Ottawa including; France, Spain, Italy, Belgium, European Community, and Brazil. Dr. Barnabe has also worked as a Technology Scout and Transfer Agent for numerous universities, private and public companies and US states in the biotechnology sector over the past 28 years. Furthermore, he has worked with a number of small capital companies to help raise seed capital. During the 1980's, he was an advisor to Canada's Ministry of Health and Health Protection Branch during the AIDS epidemic. Dr. Barnabe is a Knight of the National Order of Brazil and Commander of the National Order of Service in Spain. He has obtained a long and very successful career in both medicine and technology. "We're delighted Dr. Barnabe is joining us at Nano Labs Corp.," stated Mr. Bernardo Chavarria, President of Nano Labs. "As our business develops and new directions in product innovation are taken, Dr. Barnabe is sure to bring valuable insight to the company in the fields of healthcare, medicine and related industrial applications." About Nano Labs Nano Labs Corp. (CTLE) is a nanotechnology company which began during October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material. The Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit www.NanoLabs.us . The Nano Labs Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=16293 Forward looking statements This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company's news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.
CONTACT: Nano Labs Corp. Bernardo Camacho Chavarria President 1 (888) 806-2315